Common questions about PROGIRON (FAQ)
Q: What should I do if I forget to use a scheduled dose of PROGIRON?
The official procedure for a missed oral dose is that the regulatory procedure describes taking the dose as soon as it is remembered. However, if it is almost time for your next scheduled dose, the instruction is that the missed dose is skipped entirely. Regulatory documents state that a double dose must never be taken to make up for a missed dose.
Q: Can PROGIRON affect the results of common lab tests?
Official labeling indicates that progesterone medications can be associated with changes in the results of certain common laboratory tests. This interference may involve analyses such as those that measure blood lipids, coagulation factors (related to clotting), and how the body handles glucose (sugar). Regulatory labeling includes a recommendation that the laboratory or healthcare provider be informed that PROGIRON is being used before any tests are performed.
Q: Can PROGIRON be used by people with a history of liver issues?
The use of PROGIRON is formally contraindicated (officially restricted from use) in individuals who have known or active severe liver disease or dysfunction. For patients with a less severe history of hepatic (liver) function concerns, regulatory information states that the use requires careful observation and monitoring.
Q: Is PROGIRON safe to use while breastfeeding?
Official labeling indicates that the use of PROGIRON is not recommended while breastfeeding. While some studies suggest that the medication may pose minimal risk to an infant, the product's official classification remains cautious for women who are breastfeeding.
Q: Are there any reported long-term effects of using PROGIRON for many years?
Regulatory warnings for this class of hormones are often informed by large, long-term studies exploring risks associated with menopausal hormone therapy (MHT) over several years of use. These studies examined potential risks such as blood clots and breast cancer. The relevance of these findings is noted in official documentation, and official documentation includes warnings regarding the potential risks for the hormone class.
Q: Does PROGIRON need to be refrigerated?
PROGIRON is officially required to be stored at a controlled room temperature, typically specified to be between 15 C and 30 C (59 F and 86 F). Official requirements explicitly state that the product must not be refrigerated or frozen, as this may compromise its stability.
Q: Is PROGIRON a type of antibiotic?
No. PROGIRON is classified as a Progestogen, a type of medication that acts as a Female Sex Hormone. Its active ingredient is Progesterone, and it is used for hormone replacement or physiological balancing, not for treating bacterial infections.
Q: How long does it usually take for PROGIRON to start having an effect?
Following oral administration, pharmacokinetic data show that the level of progesterone in the blood typically reaches its maximum concentration within approximately 2 to 4 hours. The full intended clinical effect on the uterine lining is a slower biological process that develops over the planned course of treatment.
Q: What happens if I stop using PROGIRON suddenly?
Official patient information contains a precaution against stopping the use of PROGIRON suddenly without consultation. For patients using the intramuscular regimen for conditions like secondary amenorrhea (lack of menstruation), a consequence of stopping treatment is expected withdrawal bleeding, which generally begins 48 to 72 hours after the final dose.
Q: Why is PROGIRON sometimes given as an injection instead of a tablet?
PROGIRON is offered in multiple forms to address the poor and rapid metabolism of the oral form. Regulatory documents indicate that the injectable route is used to achieve specific, higher concentrations of the hormone in the bloodstream. This may be required to support certain treatment goals, such as those required for luteal phase support.
Q: Is it common to feel tired when starting PROGIRON?
Fatigue and lassitude (tiredness) are listed in official safety documents as a common side effect, meaning they are reported to affect 1 to 10 users in every 100. Other related effects, such as dizziness and somnolence (drowsiness), are also documented in the product information.
Q: If PROGIRON is described as having 'limited research', what does that mean?
Phrases like 'limited research' or 'low certainty' in official drug reviews mean the available studies may not provide a high level of confidence in the outcome across all possible patient groups, or that more research is needed to determine the best approach. The findings are considered only applicable to the specific population that was studied in the clinical trials.
Q: What is the risk of an allergic reaction to PROGIRON?
Hypersensitivity (a severe allergic reaction) to any component is a formal contraindication for using the medication. Official labeling notes the presence of peanut oil in some formulations of the oral capsule, which is a major allergen and represents a formal contraindication for patients with a known peanut allergy.
Q: Does PROGIRON affect blood pressure?
While blood pressure changes are not listed as common side effects, postmarketing reports in official documentation have included instances of both high blood pressure (hypertension) and low blood pressure (hypotension). Additionally, the use of PROGIRON in patients with pre-existing high blood pressure requires careful observation.
